Nicola Goatman[email protected]MRIMore T, doctor? No thanksAs the European market recovers from economic turmoil, cost is an ever important factor in MRI purchasing decisions, and advanced 1.5-tesla systems are likely to account for a far higher proportion of unit shipments compared with 3-tesla systems over the next five years.March 11, 2015Page 1 of 1Top StoriesMolecular ImagingNew PET tracer shows promise for guiding pancreatic cancer therapyThe radiotracer is designed to identify pancreatic tumors eligible for paired therapy with cancer-killing actinium-225 (Ac-225) NMT25.Womens ImagingSIIM: CVMs on par with LLMs for labeling incidental breast findingsBreastPET/CT could improve margin assessment for breast tumorsPodcast NetworkWomen's Imaging MinnieCast, Episode 11: Could AI be the future of BI-RADS?Technology ReviewFrom products to pathways: The new frontier of MedTech innovation
